Invasive procedures for overactive bladder in women
Invasive procedures for overactive bladder in women
Management is undertaken via a specialist team.
Options include:
- augmentation cystoplasty restricted for the management of idiopathic detrusor overactivity to women whose condition has not responded to non-surgical management and who are willing and able to self-catheterise
- bladder wall injection with botulinum toxin type A1 to women with OAB caused by detrusor overactivity that has not responded to non-surgical management, including pharmacological treatments
- risk of adverse effects, including an increased risk of urinary tract infection
- start treatment only if the woman is willing, in the event of developing significant voiding dysfunction: to perform clean intermittent catheterisation on a regular basis for as long as needed or to accept a temporary indwelling catheter if she is unable to perform clean intermittent catheterisation.
- percutaneous posterior tibial nerve stimulation
- non-surgical management including OAB medicine treatment has not worked adequately and the woman does not want botulinum toxin type A1 or percutaneous sacral nerve stimulation
- non-surgical management including OAB medicine treatment has not worked adequately and the woman does not want botulinum toxin type A1 or percutaneous sacral nerve stimulation
- percutaneous sacral nerve stimulation
- urinary diversion
- considered for a woman with OAB only when non-surgical management has failed, and if botulinum toxin A1, percutaneous sacral nerve stimulation and augmentation cystoplasty are not appropriate or are unacceptable to her
Reference:
Related pages
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.